Sigma Planning Corp’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,970	Closed	-$233K	–	1010
2019 Q1	$233K	Buy	+2,970	New	+$233K	0.01%	773
2018 Q4	–	Sell	-2,106	Closed	-$361K	–	896
2018 Q3	$361K	Buy	+2,106	New	+$361K	0.02%	601